EECP Pakistan | EECP Heart Treatment Therapy
EECP - Enhanced External Counter Pulsation

Dr. Armughan Riaz
MBBS, Dip Card
EECP Consultant Cardiologist

EECP is a FDA approved nonivasive out patient therapy for Angina Myocardial infarction & Heart failure. No Side effects, Results equal to bypass surgery.Cost effective, covered by many insurance companies. If you or someone you love suffers from angina or congestive heart failure, you will find your visit to EECP Heart Clinic web site both informative and potentially life saving

EECP Indications

Who should have course of Enhanced External Counter pulsation. Indications of EECP ECP therapy.

indications of eecp EECP Indications

Patient Selection and Treatment
EECP therapy is a safe and effective treatment that provides sustained duration of benefit in patients with disabling angina and angina equivalents, left ventricular dysfunction (LVD), and heart failure.

EECP therapy is indicated for use in
(A) stable and unstable angina pectoris, (B) congestive heart failure, (C) acute myocardial infarction, and (D) cardiogenic shock.

Patients that may benefit from EECP Therapy,

-Patients with *angina or angina equivalents:
Who No longer respond to medical therapy
Who Restrict their activities to avoid angina symptoms
Who Are unwilling to undergo additional invasive revascularization procedures
-Have LVD (EF <35%)
-Have co-morbid conditions that increase the risk of revascularization procedures (e.g., diabetes, heart failure, pulmonary disease, renal dysfunction)
-Have coronary anatomy unsuitable for surgical or catheter-based Revascularization
-Are considered inoperable or at high risk of operative/interventional Complications
-Suffer with microvascular angina (Cardiac Syndrome X) Heart failure patients* in a euvolemic state with:
-Ischemic or idiopathic cardiomyopathy LVD (EF <35%)
-Co-morbid conditions that increase the risk of complications of revascularization procedures
-Diabetic patients known to be at greater risk for post-procedural complications.
-Elderly patients at high risk for morbidity and mortality associated with invasive coronary interventions.
-Patient is non affording and cant bear high charges of angioplasty or bypass.